• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

遗传性弥漫性胃癌:一个家族的故事。

Hereditary diffuse gastric cancer: One family's story.

作者信息

Zylberberg Haley M, Sultan Keith, Rubin Steven

机构信息

Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY 11549, United States.

Division of Gastroenterology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Manhasset, NY 11030, United States.

出版信息

World J Clin Cases. 2018 Jan 16;6(1):1-5. doi: 10.12998/wjcc.v6.i1.1.

DOI:10.12998/wjcc.v6.i1.1
PMID:29376063
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5767847/
Abstract

Hereditary diffuse gastric cancer (HDGC) is an inherited form of gastric cancer that carries a poor prognosis. Most HDGCs are caused by an autosomal dominant genetic mutation in the CDH1 gene, which carries a 70%-80% lifetime risk of gastric cancer. Given its submucosal origin, endoscopic surveillance is an unreliable means of early detection, and prophylactic gastrectomy is recommended for CDH1 positive individuals older than age 20 years. We describe the case of a male with recurrent gastric cancer who was diagnosed with HDGC secondary to the CDH1 mutation, and we also describe the patient's pedigree and outcomes of recommended genetic testing.

摘要

遗传性弥漫性胃癌(HDGC)是一种遗传性胃癌,预后较差。大多数HDGC是由CDH1基因的常染色体显性基因突变引起的,该基因突变携带者患胃癌的终生风险为70%-80%。鉴于其起源于黏膜下层,内镜监测是早期检测的不可靠手段,对于20岁以上的CDH1阳性个体,建议进行预防性胃切除术。我们描述了一例复发性胃癌男性患者,该患者被诊断为继发于CDH1突变的HDGC,我们还描述了患者的家系以及推荐的基因检测结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5e9/5767847/adced559d8db/WJCC-6-1-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5e9/5767847/37bfa35cd140/WJCC-6-1-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5e9/5767847/adced559d8db/WJCC-6-1-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5e9/5767847/37bfa35cd140/WJCC-6-1-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5e9/5767847/adced559d8db/WJCC-6-1-g002.jpg

相似文献

1
Hereditary diffuse gastric cancer: One family's story.遗传性弥漫性胃癌:一个家族的故事。
World J Clin Cases. 2018 Jan 16;6(1):1-5. doi: 10.12998/wjcc.v6.i1.1.
2
Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1.CDH1 种系突变患者中遗传性弥漫性胃癌检测标准和结果的准确性。
Gastroenterology. 2015 Oct;149(4):897-906.e19. doi: 10.1053/j.gastro.2015.06.003. Epub 2015 Jun 11.
3
Hereditary diffuse gastric cancer: implications of genetic testing for screening and prophylactic surgery.遗传性弥漫性胃癌:基因检测对筛查和预防性手术的意义
Cancer. 2008 Oct 1;113(7 Suppl):1850-6. doi: 10.1002/cncr.23650.
4
CDH1 (E-Cadherin) Mutation and Gastric Cancer: Genetics, Molecular Mechanisms and Guidelines for Management.CDH1(E-钙黏蛋白)突变与胃癌:遗传学、分子机制及管理指南
Cancer Manag Res. 2019 Dec 13;11:10477-10486. doi: 10.2147/CMAR.S208818. eCollection 2019.
5
CDH1 Gene and Hereditary Diffuse Gastric Cancer Syndrome: Molecular and Histological Alterations and Implications for Diagnosis And Treatment.CDH1基因与遗传性弥漫性胃癌综合征:分子与组织学改变及其对诊断和治疗的意义
Front Pharmacol. 2018 Dec 5;9:1421. doi: 10.3389/fphar.2018.01421. eCollection 2018.
6
The role of endoscopy in the management of hereditary diffuse gastric cancer syndrome.内镜在遗传性弥漫性胃癌综合征治疗中的作用。
World J Gastroenterol. 2019 Jun 21;25(23):2878-2886. doi: 10.3748/wjg.v25.i23.2878.
7
Cleft lip/palate and hereditary diffuse gastric cancer: report of a family harboring a CDH1 c.687 + 1G > A germline mutation and review of the literature.唇腭裂和遗传性弥漫性胃癌:携带有 CDH1 c.687 + 1G > A 种系突变的家族报告及文献复习。
Fam Cancer. 2019 Apr;18(2):253-260. doi: 10.1007/s10689-018-0111-5.
8
Hereditary diffuse gastric cancer: What the clinician should know.遗传性弥漫性胃癌:临床医生应了解的内容。
World J Gastrointest Oncol. 2015 Sep 15;7(9):153-60. doi: 10.4251/wjgo.v7.i9.153.
9
[Hereditary diffuse gastric cancer].[遗传性弥漫性胃癌]
Klin Onkol. 2012;25 Suppl:S30-3.
10
CDH1 associated gastric cancer: a report of a family and review of the literature.CDH1相关的胃癌:一个家族报告及文献综述
Eur J Surg Oncol. 2005 Apr;31(3):259-64. doi: 10.1016/j.ejso.2004.12.010.

引用本文的文献

1
Significance of E-cadherin Gene Mutations in Patients With Hereditary Diffuse Gastric Cancer Syndrome: A Systematic Review.E-钙黏蛋白基因突变在遗传性弥漫性胃癌综合征患者中的意义:一项系统评价
Cureus. 2020 Sep 12;12(9):e10406. doi: 10.7759/cureus.10406.
2
Gastric carcinoma: Insights into risk factors, methods of diagnosis, possible lines of management, and the role of primary care.胃癌:对危险因素、诊断方法、可能的治疗方案以及初级保健作用的见解。
J Family Med Prim Care. 2020 Jun 30;9(6):2659-2663. doi: 10.4103/jfmpc.jfmpc_527_20. eCollection 2020 Jun.
3
Mutation Distribution and Type Suggests Genetic Differences between the Etiology of Orofacial Clefting and Gastric Cancer.

本文引用的文献

1
Gastric cancer.胃癌。
Lancet. 2016 Nov 26;388(10060):2654-2664. doi: 10.1016/S0140-6736(16)30354-3. Epub 2016 May 5.
2
Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers.遗传性弥漫性胃癌:强调种系CDH1突变携带者的最新临床指南
J Med Genet. 2015 Jun;52(6):361-74. doi: 10.1136/jmedgenet-2015-103094. Epub 2015 May 15.
3
Hereditary diffuse gastric cancer: a family diagnosis and treatment.遗传性弥漫性胃癌:家族性诊断与治疗
基因突变分布和类型提示口腔颌面裂和胃癌病因的遗传差异。
Genes (Basel). 2020 Apr 3;11(4):391. doi: 10.3390/genes11040391.
4
Effect of docetaxel-loaded lipid microbubble in combination with ultrasound-triggered microbubble destruction on the growth of a gastric cancer cell line.载多西他赛脂质微泡联合超声触发微泡破坏对胃癌细胞系生长的影响
Oncol Lett. 2019 Jul;18(1):442-448. doi: 10.3892/ol.2019.10289. Epub 2019 Apr 30.
5
Diffuse Gastric Cancer: A Summary of Analogous Contributing Factors for Its Molecular Pathogenicity.弥漫性胃癌:分子发病机制相似促成因素概述。
Int J Mol Sci. 2018 Aug 16;19(8):2424. doi: 10.3390/ijms19082424.
6
Molecular biology as a tool for the treatment of cancer.分子生物学作为癌症治疗的一种手段。
Clin Exp Med. 2018 Nov;18(4):457-464. doi: 10.1007/s10238-018-0518-1. Epub 2018 Jul 13.
Clin Med Res. 2013 Feb;11(1):36-41. doi: 10.3121/cmr.2012.1071. Epub 2012 Jun 21.
4
Molecular classification of gastric cancer: a new paradigm.胃癌的分子分类:一种新的范例。
Clin Cancer Res. 2011 May 1;17(9):2693-701. doi: 10.1158/1078-0432.CCR-10-2203. Epub 2011 Mar 23.
5
Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research.遗传性弥漫型胃癌:临床管理的更新共识指南和未来研究方向。
J Med Genet. 2010 Jul;47(7):436-44. doi: 10.1136/jmg.2009.074237.
6
Mechanisms and sequelae of E-cadherin silencing in hereditary diffuse gastric cancer.遗传性弥漫性胃癌中E-钙黏蛋白沉默的机制及后遗症
J Pathol. 2008 Nov;216(3):295-306. doi: 10.1002/path.2426.
7
Hereditary diffuse gastric cancer: diagnosis, genetic counseling, and prophylactic total gastrectomy.遗传性弥漫性胃癌:诊断、遗传咨询及预防性全胃切除术
Cancer. 2008 Jun 15;112(12):2655-63. doi: 10.1002/cncr.23501.
8
Diffuse and intestinal type gastric carcinomas differ in their expression of apoptosis related proteins.弥漫型和肠型胃癌在凋亡相关蛋白的表达上存在差异。
J Clin Pathol. 2003 Sep;56(9):699-702. doi: 10.1136/jcp.56.9.699.
9
E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma.E-钙黏蛋白基因(CDH1)启动子甲基化作为散发性弥漫型胃癌的第二次打击。
Oncogene. 2001 Mar 22;20(12):1525-8. doi: 10.1038/sj.onc.1204234.
10
Pathology and prognosis of gastric carcinoma: well versus poorly differentiated type.胃癌的病理学与预后:高分化型与低分化型对比
Cancer. 2000 Oct 1;89(7):1418-24.